NCT03483818View on ClinicalTrials.gov

Pilot Trial of Directly Observed Anti HCV Therapy & Contingency Management in a Population on Opiate Substitute Therapy

NACompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

November 30, 2016

Conditions
Hepatitis C
Interventions
PROCEDURE

Assessment & Treatment of HCV infection with oral antivirals

This is a cluster randomised trial of directly observed anti HCV therapy versus conventional care in HCV positive patients, who are in a pharmacist delivered OST program, where the patients attending an individual pharmacist are the cluster. Pharmacies participating in the trial will be allocated to conventional care pathway or the pharmacist-led pathway.

Trial Locations (1)

DD1 9SY

Ninewells Hospital, Dundee

All Listed Sponsors
collaborator

University of Dundee

OTHER

lead

NHS Tayside

OTHER_GOV

NCT03483818 - Pilot Trial of Directly Observed Anti HCV Therapy & Contingency Management in a Population on Opiate Substitute Therapy | Biotech Hunter | Biotech Hunter